Filter
2831
Text search:
medicines
safety
Featured
Recommendations
339
New Publications
786
Language
Document type
No document type
1329
Guidelines
510
Studies & Reports
471
Manuals
196
Strategic & Response Plan
154
Fact sheets
62
Training Material
43
Situation Updates
33
Resource Platforms
11
Brochures
10
Infographics
6
Online Courses
4
Videos
2
Countries / Regions
Global
119
India
107
Kenya
91
South Africa
75
Ethiopia
70
Uganda
63
Liberia
58
Nigeria
57
Sierra Leone
55
Western and Central Europe
52
Nepal
47
Tanzania
45
Myanmar / Burma
45
Bangladesh
44
Ghana
43
Zambia
42
Africa
40
Malawi
38
Latin America and the Carribbean
37
Namibia
34
Ukraine
34
Syria
30
Rwanda
30
Congo, Democratic Republic of
27
Philippines
25
South–East Asia Region
21
Eastern Europe
19
Asia
18
Zimbabwe
17
Guinea
16
Haiti
14
South Sudan
14
Cambodia
13
Indonesia
13
Lesotho
13
Middle East and North Africa
13
West and Central Africa
12
Eastern Europe and Central Asia
12
Pakistan
11
Brazil
11
Mozambique
10
Botswana
10
Yemen
10
Russia
10
Afghanistan
9
Sudan
9
East and Southern Africa
9
Venezuela
9
Vietnam
8
Burkina Faso
7
Cameroon
7
Somalia
7
Thailand
7
Eswatini/ Swaziland
7
Senegal
6
Germany
6
Lebanon
6
Western Pacific Region
6
Laos
6
Moldova
6
Central African Republic
5
Iraq
4
Jordan
4
Peru
4
Colombia
4
Libya
4
Madagascar
4
Bhutan
4
Tajikistan
4
United Kingdom
4
Mali
3
China
3
Argentina
3
North Macedonia
3
Sri Lanka
3
Poland
3
Palestine
3
Albania
3
Georgia
3
North America
3
Mauritius
3
Côte d’Ivoire / Ivory Coast
2
USA
2
Saudi Arabia
2
Turkey
2
Egypt
2
Papua New Guinea
2
Switzerland
2
Ecuador
2
El Salvador
2
Bolivia
2
Angola
2
Chile
2
Southern Africa
2
Timor Leste/ East Timor
2
Qatar
2
Romania
2
Iran
2
Gabon
2
Turkmenistan
2
Guinea-Bissau
1
Morocco
1
Niger
1
Togo
1
Chad
1
Gambia
1
Benin
1
Serbia
1
Hungary
1
Burundi
1
Mexico
1
Paraguay
1
Fiji
1
Djibouti
1
Armenia
1
Canada
1
Bulgaria
1
Lithuania
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
Japan
1
Denmark
1
Maldives
1
Tunisia
1
Belarus
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
1104
Clinical Guidelines
284
Public Health
174
Women & Child Health
135
Key Resources
130
Pharmacy & Technologies
41
Capacity Building
40
Toolboxes
COVID-19
252
HIV
202
AMR
196
Pharmacy
164
TB
151
Mental Health
150
Caregiver
83
NTDs
77
Conflict
76
Ebola & Marburg
70
Planetary Health
58
Disability
57
NCDs
57
Rapid Response
46
Global Health Education
46
Malaria
46
Refugee
45
Natural Hazards
35
2.0 Rapid Response
19
Health Financing Toolbox
18
Zika
13
Cholera
7
Specific Hazards
7
Polio
6
Social Ethics
3
Kenya Quality Model for Health - Health Facilities
Accessed July 2014
Given that the emergency has exceeded the worst-case scenario, this revised supplementary appeal for the Ukraine situation outlines UNHCR’s additional requirements of $1.246 billion for March to December 2022.
24 September 2021. The vaccine has been authorized by the Chinese National Regulatory Authority (NRA) – the National Medicinal Product Administration (NMPA) – as well as other regulatory authorities. Because WHO has granted Emergency Use Listing (EUL) for the Sinovac COVID-19 vaccine (Vero Cell
...
2016 ASCO EDUCATIONAL BOOK | asco.org/edbo
Accessed at March 2014
The Ministry of Health and Social Services has the mandate to fulfil one of the aspirations in Namibia’s Vision 2030 to “transform Namibia into a healthy and food-secure nation”. Namibia strives to provide quality health and social welfare services efficiently and effectively to the population
...
Tuberculosis (TB) is among the top ten most common causes of death globally and as a single infectious disease it top among infectious diseases. Furthermore, it is noted as the top causes of death among people infected with the human immunodeficiency virus (HIV). Despite recent decreases in the numb
...
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable treatments for the most neglected patients
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This
...